SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-22-000892
Filing Date
2022-05-13
Accepted
2022-05-12 19:47:59
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e3769_10-q.htm   iXBRL 10-Q 844029
2 EXHIBIT 31.1 e3769_ex31-1.htm EX-31.1 8616
3 EXHIBIT 31.2 e3769_ex31-2.htm EX-31.2 8162
4 EXHIBIT 32.1 e3769_ex32-1.htm EX-32.1 4543
5 EXHIBIT 32.2 e3769_ex32-2.htm EX-32.2 4558
  Complete submission text file 0001731122-22-000892.txt   4738040

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enob-20220331.xsd EX-101.SCH 39894
7 XBRL CALCULATION FILE enob-20220331_cal.xml EX-101.CAL 53773
8 XBRL DEFINITION FILE enob-20220331_def.xml EX-101.DEF 169786
9 XBRL LABEL FILE enob-20220331_lab.xml EX-101.LAB 337609
10 XBRL PRESENTATION FILE enob-20220331_pre.xml EX-101.PRE 278707
54 EXTRACTED XBRL INSTANCE DOCUMENT e3769_10-q_htm.xml XML 668780
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38758 | Film No.: 22919673
SIC: 2834 Pharmaceutical Preparations